Given that the COVID-19 crisis continues to be a global healthcare concern, it’s no secret that healthcare stocks are riding high in the wake of the pandemic. New roll-out vaccines, COVID-19 therapies, and other hospital/doctor needs have continued to drive strong earnings and cash flow growth over the last year. And as such, healthcare stock prices have followed suit.
The best part is that the sector could have even more in store for the new year.
From the booming economy and the onset of new COVID-19 variants to advances in groundbreaking technologies and high-tech therapies, the prognosis for the healthcare sector looks good in 2022. Adding in the sector’s low valuations, rich dividend growth and a favorable regulatory environment, healthcare could be a top winner for income investors going forward.
Our Best Dividend Stocks Model Portfolio has some of the highest-rated stocks by our proprietary Dividend Safety rating system. Go Premium to find out the entire list.
